PDB Short entry for 4MY6 HEADER CELL ADHESION/INHIBITOR 27-SEP-13 4MY6 TITLE ENAH-EVH1 IN COMPLEX WITH PEPTIDOMIMETIC LOW-MOLECULAR WEIGHT TITLE 2 INHIBITOR AC-[2-CL-F]-[PROM-2]-[PROM-1]-OH COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN ENABLED HOMOLOG; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: EVH1 DOMAIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ENAH, MENA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PGEX-4T1 KEYWDS MOLECULAR RECOGNITION, ACTIN DYNAMICS, CELL ADHESION-INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.BARONE,Y.ROSKE,R.KUEHNE REVDAT 6 20-SEP-23 4MY6 1 REMARK SEQADV REVDAT 5 22-JUL-15 4MY6 1 TITLE REVDAT 4 06-MAY-15 4MY6 1 JRNL REVDAT 3 22-APR-15 4MY6 1 JRNL REVDAT 2 15-APR-15 4MY6 1 JRNL REVDAT 1 15-OCT-14 4MY6 0 JRNL AUTH R.OPITZ,M.MULLER,C.REUTER,M.BARONE,A.SOICKE,Y.ROSKE, JRNL AUTH 2 K.PIOTUKH,P.HUY,M.BEERBAUM,B.WIESNER,M.BEYERMANN, JRNL AUTH 3 P.SCHMIEDER,C.FREUND,R.VOLKMER,H.OSCHKINAT,H.G.SCHMALZ, JRNL AUTH 4 R.KUHNE JRNL TITL A MODULAR TOOLKIT TO INHIBIT PROLINE-RICH MOTIF-MEDIATED JRNL TITL 2 PROTEIN-PROTEIN INTERACTIONS. JRNL REF PROC.NATL.ACAD.SCI.USA V. 112 5011 2015 JRNL REFN ISSN 0027-8424 JRNL PMID 25848013 JRNL DOI 10.1073/PNAS.1422054112 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.06 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 23659 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : 0.238 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1183 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1752 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 98 REMARK 3 SOLVENT ATOMS : 164 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4MY6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-OCT-13. REMARK 100 THE DEPOSITION ID IS D_1000082513. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-JUN-12 REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : 0.91841 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23659 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 35.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.07400 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 4.0200 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.74 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 4.11 REMARK 200 R MERGE FOR SHELL (I) : 0.58900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.350 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PDB ENTRY 1EVH REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.08 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.2M AMMONIUM SULPHATE, 200MM AMMONIUM REMARK 280 BROMIDE, PH 7, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z REMARK 290 7555 -X+1/2,Y+1/2,-Z REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 44.91500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 65.71000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 44.91500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 65.71000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 44.91500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 65.71000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 44.91500 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 65.71000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 BR BR A 202 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 327 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 MET A 1 REMARK 465 GLY B -1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH B 321 O HOH B 345 6545 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG B 81 NE - CZ - NH2 ANGL. DEV. = -4.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN B 61 88.26 -158.45 REMARK 500 REMARK 500 REMARK: NULL REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR REMARK 630 MOLECULE NAME: (3AR,5AS,8S,10AS)-1-[(3S,6R,8AS)-1'-[(2S)-2- REMARK 630 ACETAMIDO-3-(2-CHLOROPHENYL)PROPANOYL]-5-OXIDANYLIDENE-SPIRO[1,2,3, REMARK 630 8A-TETRAHYDROINDOLIZINE-6,2'-PYRROLIDINE]-3-YL]CARBONYL-10- REMARK 630 OXIDANYLIDENE-2,3,3A,5A,8,10A-HEXAHYDRODIPYRROLO[3,2-B:3',1'-F] REMARK 630 AZEPINE-8-CARBOXYLIC ACID REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 3VH A 201 REMARK 630 3VH B 201 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: ACT 2L5 2L6 2L9 REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3VH A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BR A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3VH B 201 DBREF 4MY6 A 1 111 UNP Q8N8S7 ENAH_HUMAN 1 111 DBREF 4MY6 B 1 111 UNP Q8N8S7 ENAH_HUMAN 1 111 SEQADV 4MY6 GLY A -1 UNP Q8N8S7 EXPRESSION TAG SEQADV 4MY6 SER A 0 UNP Q8N8S7 EXPRESSION TAG SEQADV 4MY6 GLY B -1 UNP Q8N8S7 EXPRESSION TAG SEQADV 4MY6 SER B 0 UNP Q8N8S7 EXPRESSION TAG SEQRES 1 A 113 GLY SER MET SER GLU GLN SER ILE CYS GLN ALA ARG ALA SEQRES 2 A 113 ALA VAL MET VAL TYR ASP ASP ALA ASN LYS LYS TRP VAL SEQRES 3 A 113 PRO ALA GLY GLY SER THR GLY PHE SER ARG VAL HIS ILE SEQRES 4 A 113 TYR HIS HIS THR GLY ASN ASN THR PHE ARG VAL VAL GLY SEQRES 5 A 113 ARG LYS ILE GLN ASP HIS GLN VAL VAL ILE ASN CYS ALA SEQRES 6 A 113 ILE PRO LYS GLY LEU LYS TYR ASN GLN ALA THR GLN THR SEQRES 7 A 113 PHE HIS GLN TRP ARG ASP ALA ARG GLN VAL TYR GLY LEU SEQRES 8 A 113 ASN PHE GLY SER LYS GLU ASP ALA ASN VAL PHE ALA SER SEQRES 9 A 113 ALA MET MET HIS ALA LEU GLU VAL LEU SEQRES 1 B 113 GLY SER MET SER GLU GLN SER ILE CYS GLN ALA ARG ALA SEQRES 2 B 113 ALA VAL MET VAL TYR ASP ASP ALA ASN LYS LYS TRP VAL SEQRES 3 B 113 PRO ALA GLY GLY SER THR GLY PHE SER ARG VAL HIS ILE SEQRES 4 B 113 TYR HIS HIS THR GLY ASN ASN THR PHE ARG VAL VAL GLY SEQRES 5 B 113 ARG LYS ILE GLN ASP HIS GLN VAL VAL ILE ASN CYS ALA SEQRES 6 B 113 ILE PRO LYS GLY LEU LYS TYR ASN GLN ALA THR GLN THR SEQRES 7 B 113 PHE HIS GLN TRP ARG ASP ALA ARG GLN VAL TYR GLY LEU SEQRES 8 B 113 ASN PHE GLY SER LYS GLU ASP ALA ASN VAL PHE ALA SER SEQRES 9 B 113 ALA MET MET HIS ALA LEU GLU VAL LEU HET 3VH A 201 48 HET BR A 202 1 HET BR A 203 1 HET 3VH B 201 48 HETNAM 3VH (3AR,5AS,8S,10AS)-1-[(3S,6R,8AS)-1'-[(2S)-2-ACETAMIDO- HETNAM 2 3VH 3-(2-CHLOROPHENYL)PROPANOYL]-5-OXIDANYLIDENE-SPIRO[1, HETNAM 3 3VH 2,3,8A-TETRAHYDROINDOLIZINE-6,2'-PYRROLIDINE]-3- HETNAM 4 3VH YL]CARBONYL-10-OXIDANYLIDENE-2,3,3A,5A,8,10A- HETNAM 5 3VH HEXAHYDRODIPYRROLO[3,2-B:3',1'-F]AZEPINE-8-CARBOXYLIC HETNAM 6 3VH ACID HETNAM BR BROMIDE ION FORMUL 3 3VH 2(C35 H38 CL N5 O7) FORMUL 4 BR 2(BR 1-) FORMUL 7 HOH *164(H2 O) HELIX 1 1 GLY A 27 SER A 29 5 3 HELIX 2 2 SER A 93 LEU A 111 1 19 HELIX 3 3 SER B 93 LEU B 111 1 19 SHEET 1 A 5 LYS A 22 PRO A 25 0 SHEET 2 A 5 GLU A 3 ASP A 17 -1 N ASP A 17 O LYS A 22 SHEET 3 A 5 PHE A 32 HIS A 40 -1 O VAL A 35 N ALA A 9 SHEET 4 A 5 THR A 45 LYS A 52 -1 O VAL A 49 N HIS A 36 SHEET 5 A 5 VAL A 58 ILE A 64 -1 O CYS A 62 N VAL A 48 SHEET 1 B 5 LYS A 22 PRO A 25 0 SHEET 2 B 5 GLU A 3 ASP A 17 -1 N ASP A 17 O LYS A 22 SHEET 3 B 5 VAL A 86 PHE A 91 -1 O GLY A 88 N MET A 14 SHEET 4 B 5 PHE A 77 ARG A 81 -1 N TRP A 80 O TYR A 87 SHEET 5 B 5 ASN A 71 GLN A 72 -1 N ASN A 71 O GLN A 79 SHEET 1 C 5 LYS B 22 PRO B 25 0 SHEET 2 C 5 GLU B 3 ASP B 17 -1 N ASP B 17 O LYS B 22 SHEET 3 C 5 PHE B 32 HIS B 40 -1 O VAL B 35 N ALA B 9 SHEET 4 C 5 THR B 45 LYS B 52 -1 O VAL B 49 N HIS B 36 SHEET 5 C 5 VAL B 58 ALA B 63 -1 O CYS B 62 N VAL B 48 SHEET 1 D 5 LYS B 22 PRO B 25 0 SHEET 2 D 5 GLU B 3 ASP B 17 -1 N ASP B 17 O LYS B 22 SHEET 3 D 5 VAL B 86 PHE B 91 -1 O GLY B 88 N MET B 14 SHEET 4 D 5 PHE B 77 ARG B 81 -1 N TRP B 80 O TYR B 87 SHEET 5 D 5 ASN B 71 THR B 74 -1 N ASN B 71 O GLN B 79 SITE 1 AC1 19 TYR A 16 TRP A 23 LYS A 69 ASN A 71 SITE 2 AC1 19 PHE A 77 GLN A 79 ARG A 81 VAL A 86 SITE 3 AC1 19 HOH A 305 HOH A 308 HOH A 318 HOH A 336 SITE 4 AC1 19 HOH A 340 HOH A 380 TYR B 16 ASP B 18 SITE 5 AC1 19 ASN B 20 LYS B 22 HOH B 370 SITE 1 AC2 1 GLY A 42 SITE 1 AC3 14 ASP A 18 HOH A 380 TYR B 16 TRP B 23 SITE 2 AC3 14 ASN B 71 PHE B 77 GLN B 79 ARG B 81 SITE 3 AC3 14 VAL B 86 HOH B 330 HOH B 346 HOH B 347 SITE 4 AC3 14 HOH B 350 HOH B 352 CRYST1 89.830 131.420 35.560 90.00 90.00 90.00 C 2 2 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011132 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007609 0.000000 0.00000 SCALE3 0.000000 0.000000 0.028121 0.00000